Sydney-based biopharma Novogen's (ASX:NRT, Nasdaq:NVGN) US subsidiary, Glycotex, has appointed Dr Reinhard Koenig as CEO and president. [ + ]

A phase Ib clinical trial of Melbourne-based Phosphagenics' (ASX:POH, AIM:PSG) TPM-01 transdermal delivery system has demonstrated that therapeutic levels of morphine in plasma were achieved and maintained for more than 48 hours using the technology. [ + ]

Sydney-based drug developer Pharmaxis (ASX:PXS, Nasdaq:PXSL) has signed a European distribution agreement for its first product, Aridol. [ + ]

Melbourne and California-based ChemGenex Pharmaceuticals (ASX:CXS, Nasdaq:CXSP)) has signed a new three-year alliance agreement with industry partner Merck KGaA, of Germany, to provide preclinical support in the fields of diabetes, insulin resistance and complications. [ + ]

Internationally renowned embryonic stem cell expert Martin Pera will leave Monash University and the Australian Stem Cell Centre (ASCC) in April to head the newly created Institute for Stem Cell and Regenerative Medicine (ISCRM) at the University of Southern California. [ + ]

The failure of the anti-influenza drug Tamiflu to save the lives of patients with established H5N1 avian influenza infections may be a consequence of the drug's design, mode of delivery, and the uniqueness of the virus itself, according to experts. [ + ]

Following a board stoush last year and calls by shareholders at the company's AGM for a change in management, Polartechnics (ASX:PLT) CEO Victor Skladnev was yesterday replaced by Ben Dillon. [ + ]

Melbourne based adult stem cell company, Mesoblast (ASX:MSB), has been granted what it says is a key adult stem cell patent. [ + ]

Winston Churchill called it his 'black dog'. Abraham Lincoln suffered from bipolar disorder, as did German composer Robert Schumann, and Dutch artist Vincent van Gogh. And a slew of poets including Alfred Lord Tennyson, William Blake, Edgar Allan Poe, Lord Byron and Sylvia Plath lived with manic depression. [ + ]

For the first time DNA analysis can identify paper-degrading microorganisms. This is made possible by a molecular process developed for fungal infected documents at the University of Vienna with support from the Austrian Science Fund FWF.

Rutgers, the state university of New Jersey, USA, researchers have found that the curry spice turmeric holds real potential for the treatment and prevention of prostate cancer, particularly when combined with certain vegetables.

Tissue engineering specialist Clinical Cell Culture's (ASX:CCE, C3) share price took a blow today, in the wake of a request by the US Food and Drug Administration (FDA) for more performance data before it can approve C3's ReCell for sale in the US. [ + ]

EvoGenix (ASX:EGX) has reported results on the development of its product OVP, for the treatment of bone loss. [ + ]

The research community has paid tribute to Justice John Lockhart, the chair of a recently concluded review of Australia's stem cell legislation, who died in Sydney on Friday after a brief illness. [ + ]

A team of scientists at the Weizmann Institute of Science in Israel, led by Professor Michal Schwartz of the Neurobiology Department, has come up with new findings that may have implications in delaying and slowing down cognitive deterioration in old age.